American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Latest News

Walgreens to go private in $10B deal with Sycamore: how the pharmacy giant fell from grace

by admin March 8, 2025
March 8, 2025
Walgreens to go private in $10B deal with Sycamore: how the pharmacy giant fell from grace

Walgreens Boots Alliance will be taken private by Sycamore Partners in a $10 billion deal, the companies announced Thursday, marking the end of nearly a century of public trading for the US pharmacy giant.

The move comes after years of financial turbulence that saw Walgreens’ market value plummet from a peak of $100 billion to just $9.3 billion.

Sycamore will pay $11.45 per share, an 8% premium over Walgreens’ closing price of $10.60 on Thursday.

In addition, shareholders could receive up to $3 per share in cash from future monetization of Walgreens’ stake in primary-care provider VillageMD.

The total transaction, including debt and payouts, is valued at approximately $23.7 billion, according to investment bank Leerink Partners.

Amazon, Walmart, eat into Walgreens’ share

Walgreens has struggled to keep pace with changes in the retail pharmacy landscape, losing ground to competitors such as Amazon and Walmart.

While rivals diversified into insurance and prescription management, Walgreens pursued an aggressive expansion strategy, investing billions into acquiring other pharmacy chains, including European giant Alliance Boots.

However, the shift away from brick-and-mortar retail left the company exposed to declining foot traffic and shrinking drug margins.

The company’s market capitalization has fallen by 90% since 2015, and its debt burden has swelled to nearly $30 billion.

Walgreens reported a net loss of $8.6 billion for the 2024 fiscal year, nearly three times the previous year’s losses.

While the company recently surpassed earnings and revenue expectations in its most recent quarter, analysts say the turnaround remains a long-term challenge.

“You have a business that is shrinking, and then you layer on losses and cash burn, all of that was the perfect recipe for what we are seeing today,” said Brian Tanquilut, a healthcare services research analyst at Jefferies in a Reuters report.

Strategic missteps by leadership compounded woes

Walgreens has spent years exploring potential buyers for parts of its business.

In 2019, private equity firm KKR reportedly offered $70 billion to take the company private, but the talks did not advance.

Now, Sycamore’s acquisition comes at a fraction of that valuation.

The company has also suffered from strategic missteps under former CEO Stefano Pessina, its largest single shareholder.

During his tenure, Walgreens’ market capitalization shrank by nearly half, and its expansion strategy failed to yield long-term gains.

The costly $5.2 billion investment in VillageMD, once seen as a path to healthcare diversification, has now become a financial drain and a potential divestment target for Sycamore.

Meanwhile, Walgreens’ main competitor, CVS, has successfully diversified its business beyond retail, acquiring health insurer Aetna for nearly $70 billion in 2018.

Walgreens reportedly considered buying insurer Humana but ultimately abandoned the idea, a move analysts now see as a missed opportunity.

Sycamore’s turnaround strategy

Sycamore, a private equity firm known for acquiring struggling retail brands, has a history of extracting value through cost-cutting measures, store closures, and asset sales.

The firm has previously acquired brands such as Staples, Talbots, and Nine West, often restructuring their operations to improve profitability.

Analysts expect Sycamore to follow a similar playbook with Walgreens, possibly selling off non-core assets like Boots, its UK-based pharmacy chain, and reducing operational costs across its retail footprint.

“Going private makes sense on paper,” said Ann Hynes, an analyst with Mizuho Bank, adding that Walgreens’ operational challenges would likely be better handled without commitments to shareholders.

Deal structure and potential roadblocks

The transaction includes a 35-day “go-shop” period, allowing Walgreens to solicit alternative bids.

However, analysts believe a competing offer is unlikely given the complexity of the deal.

“Given the size and number of moving parts involved—a potential split of the US business, Boots, and Health—we don’t expect a competing bid to emerge,” said Michael Cherny, an analyst at Leerink Partners.

With Walgreens set to go private, the future of its sprawling global operations remains uncertain.

While Sycamore’s takeover provides an opportunity for restructuring, questions remain about whether the firm’s strategy will lead to long-term growth or simply a short-term financial overhaul.

Investors and industry watchers will be closely monitoring the next steps as one of America’s most storied pharmacy chains transitions to a new chapter under private ownership.

The post Walgreens to go private in $10B deal with Sycamore: how the pharmacy giant fell from grace appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Europeans are embracing EVs while Tesla is imploding: here’s why
next post
China’s gold reserves rise for fourth straight month amid escalating US trade tensions

Related Posts

Around 170 ‘executed’ in three Burkina Faso villages,...

March 6, 2024

Trump and Musk slash federal workforce as mass...

February 15, 2025

Russian-controlled Zaporizhzhia nuclear reactor damaged following drone attack

April 9, 2024

Israeli hostage families seek justice with war crimes...

February 16, 2024

Five dead and 49 missing as multi-story building...

May 8, 2024

Iranian president-elect ready to set relations with Europe...

July 15, 2024

Eight Chinese migrants found dead on Mexico beach...

April 4, 2024

One dead, seven missing after two Japanese military...

April 22, 2024

Goldman Sachs forecasts gold at $3,700/oz by year-end...

April 14, 2025

China’s LGBTQ+ community celebrates rare scenes from Paris...

July 31, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Saudi Arabia poised to raise September crude prices to five-month highs

      July 28, 2025
    • From $824 to over $1,300: how soaring rents are consuming American paychecks

      July 27, 2025
    • India-UK sign historic free trade deal: here’s all you need to know

      July 24, 2025
    • Talen Energy surges 25% to ATH after strategic natural gas power plant acquisition

      July 20, 2025
    • Trump sues Murdoch and News Corp over Wall Street Journal’s Epstein report

      July 20, 2025

    Categories

    • Business (3,540)
    • Investing (2,681)
    • Latest News (2,024)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved